Klinisch relevante Atemtests in der gastroenterologischen Diagnostik - Empfehlungen der Deutschen Gesellschaft für Neurogastroenterologie und Motilität sowie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselerkrankungen

J. Keller; A. Franke; M. Storr; F. Wiedbrauck; J. Schirra

doi:10.1055/s-2005-858479

Zeitschrift für Gastroenterologie, Table of Contents

Z Gastroenterol 2005; 43(9): 1071-1090
DOI: 10.1055/s-2005-858479

Übersicht

Klinisch relevante Atemtests in der gastroenterologischen Diagnostik - Empfehlungen der Deutschen Gesellschaft für Neurogastroenterologie und Motilität sowie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselerkrankungen

Clinically Relevant Breath Tests in Gastroenterological Diagnostics - Recommendations of the German Society for Neurogastroenterology and Motility as well as the German Society for Digestive and Metabolic DiseasesJ. Keller¹ , A. Franke² , M. Storr³ , F. Wiedbrauck⁴ , J. Schirra³

¹Israelitisches Krankenhaus, Medizinische Klinik, Hamburg
²Universitätsklinikum Mannheim, II Med. Klinik, Mannheim
³Ludwig-Maximilians-Universität, Medizinische Klinik II - Großhadern, München
⁴Allg. Krankenhaus Celle, Klinik für Gastroenterologie, Celle

Abstract

Zusammenfassung

H₂- und ¹³C-Atemtests sind wertvolle, nicht invasive diagnostische Verfahren in der Gastroenterologie. H₂-Atemtests sind klinisch etabliert zur Diagnostik einer Kohlenhydratmalabsorption und -unverträglichkeit (H₂-Atemtests mit Laktose, Fruktose, Saccharose, Sorbit), einer bakteriellen Fehlbesiedlung (H₂-Glukose-Atemtest) und zur Messung des orozökalen Transits (H₂-Laktulose-Atemtest). Der ¹³C-Harnstoffatemtest gilt als Goldstandard zur Diagnostik einer Helicobacter-pylori-Infektion. Darüber hinaus gehören ¹³C-Atemtests zur Messung der Magenentleerung mittlerweile zu den klinisch etablierten Verfahren. ¹³C-Atemtests zur Messung der exokrinen Pankreasfunktion und Leberfunktion werden klinisch ebenfalls eingesetzt, bieten aber derzeit keine wesentlichen Vorteile gegenüber anderen diagnostischen Verfahren. Ein Nachteil sämtlicher Atemtests besteht in der fehlenden Standardisierung der Testverfahren, obwohl Änderungen der Testlösung bzw. -mahlzeit, der Testdurchführung und -auswertung erheblichen Einfluss auf die Ergebnisse haben können. Dieser Artikel gibt deshalb die Empfehlungen der Deutschen Gesellschaft für Neurogastroenterologie und Motilität sowie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselerkrankungen zur Durchführung klinisch relevanter H₂- und ¹³C-Atemtests wieder. Dargestellt werden Indikationen, praktische Durchführung und Analyse der jeweiligen Untersuchungen. Die Empfehlungen stützen sich in erster Linie auf die verfügbare Literatur, berücksichtigen aber auch die praktischen Erfahrungen der Autoren, zumal zahlreiche Fragestellungen zur optimalen Durchführung einzelner Tests nicht durch adäquate Studien geklärt sind.

Abstract

H₂- and ¹³C-breath tests are valuable non-invasive diagnostic tools for gastroenterological diseases. H₂-breath tests are clinically established for the diagnosis of carbohydrate intolerance resulting from malabsorption (H₂-breath tests with lactose, fructose, saccharose, sorbitol), of bacterial overgrowth (glucose H₂-breath test) and for measurement of orcoceal transit time (lactulose H₂-breath test). The ¹³C-urea breath test is regarded as the “gold standard” procedure for the diagnosis of Helicobacter pylori infection. Moreover, ¹³C-breath tests for measurement of gastric emptying can be considered as clinically established, meanwhile. ¹³C-breath tests for the evaluation of pancreatic exocrine function or liver function can also be used clinically; however, they currently offer no substantial advantage over other diagnostic procedures. A major disadvantage of all breath tests is that they lack standardization although modifications of the test meal or solution, of the test performance and of the evaluation of data may markedly influence the results. Thus, this article presents the recommendations of the German Society of Neurogastroenterology and Motility and of the German Society of Digestive and Metabolic Diseases for clinically relevant H₂- and ¹³C-breath tests. Indications for the examinations, the procedures to be followed, the analysis of the obtained data and the conclusions to be drawn are delineated. The literature on which the recommendations are based is reviewed. However, personal experience of the authors is also taken into account since numerous questions regarding optimal test performance are not clarified by adequate studies.

Schlüsselwörter

Atemtest - Lactoseintoleranz - bakterielle Fehlbesiedlung - orozokler Transit - Heliobacter pylori - Magenentleerung - Pankreasfunktionstest - Leberfunktionstest

Key words

Breath test - lactose intolerance - bacterial overgrowth - orocecal transit - Helicobacter pylori - gastric emptying - pancreatic function test - liver function test

Full Text

References

Literatur

1 Lembcke B, Kirchhoff S, Caspary W F. [Simplified methods of expiratory hydrogen (H2) analysis clinical testing of two H2 breath test devices]. Z Gastroenterol. 1983; 21 545-549
2 Christman N T, Hamilton L H. A new chromatographic instrument for measuring trace concentrations of breath-hydrogen. J Chromatogr. 1982; 229 259-265
3 Peuhkuri K, Poussa T, Korpela R. Comparison of a portable breath hydrogen analyser (Micro H2) with a Quintron MicroLyzer in measuring lactose maldigestion, and the evaluation of a Micro H2 for diagnosing hypolactasia. Scand J Clin Lab Invest. 1998; 58 217-224
4 Lee W S, Davidson G P, Moore D J. et al . Analysis of the breath hydrogen test for carbohydrate malabsorption: validation of a pocket-sized breath test analyser. J Paediatr Child Health. 2000; 36 340-342
5 Braden B, Braden C P, Klutz M. et al . [Analysis of breath hydrogen (H2) in diagnosis of gastrointestinal function: validation of a pocket breath H2 test analyzer]. Z Gastroenterol. 1993; 31 242-245
6 Kagaya M, Iwata M, Toda Y. et al . Circadian rhythm of breath hydrogen in young women. J Gastroenterol. 1998; 33 472-476
7 Perman J A, Modler S, Barr R G. et al . Fasting breath hydrogen concentration: normal values and clinical application. Gastroenterology. 1984; 87 1358-1363
8 Romagnuolo J, Schiller D, Bailey R J. Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation. Am J Gastroenterol. 2002; 97 1113-1126
9 Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology. 1988; 95 982-988
10 Corazza G R, Strocchi A, Gasbarrini G. Fasting breath hydrogen in celiac disease. Gastroenterology. 1987; 93 53-58
11 Brummer R J, Armbrecht U, Bosaeus I. et al . The hydrogen (H2) breath test. Sampling methods and the influence of dietary fibre on fasting level. Scand J Gastroenterol. 1985; 20 1007-1013
12 Tursi A, Brandimarte G, Giorgetti G M. Sorbitol H2-breath test versus anti-endomysium antibodies for the diagnosis of subclinical/silent coeliac disease. Scand J Gastroenterol. 2001; 36 1170-1172
13 Hammer H F, Petritsch W, Pristautz H. et al . Assessment of the influence of hydrogen nonexcretion on the usefulness of the hydrogen breath test and lactose tolerance test. Wien Klin Wochenschr. 1996; 108 137-141
14 King C E, Toskes P P. Comparison of the 1-gram [14C]xylose, 10-gram lactulose-H2, and 80-gram glucose-H2 breath tests in patients with small intestine bacterial overgrowth. Gastroenterology. 1986; 91 1447-1451
15 Corazza G R, Benati G, Strocchi A. et al . The possible role of breath methane measurement in detecting carbohydrate malabsorption. J Lab Clin Med. 1994; 124 695-700
16 Metz G, Gassull M A, Drasar B S. et al . Breath-hydrogen test for small-intestinal bacterial colonisation. Lancet. 1976; 1 668-669
17 Bodamer O A, Leonard J V, Lane R E. H2-breath tests importance of adequate storage of breath samples. J Pediatr Gastroenterol Nutr. 1997; 24 450-451
18 Murray R D, Kerzner B, MacLean W C Jr. et al . Efficient storage system for breath hydrogen. J Pediatr Gastroenterol Nutr. 1985; 4 711-713
19 Rumessen J J, Gudmand-Hoyer E. Retention and variability of hydrogen (H2) samples stored in plastic syringes. Scand J Clin Lab Invest. 1987; 47 627-629
20 Saltzberg D M, Levine G M, Lubar C. Impact of age, sex, race, and functional complaints on hydrogen (H2) production. Dig Dis Sci. 1988; 33 308-313
21 Solomons N W, Garcia R, Schneider R. et al . H2 breath tests during diarrhea. Acta Paediatr Scand. 1979; 68 171-172
22 Winter B, Nothjunge J, Stern M. [Hydrogen (H2) breath test following lactose loading in children with recurrent abdominal pain]. Klin Padiatr. 1990; 202 413-416
23 Solomons N W, Viteri F, Rosenberg I H. Development of an interval sampling hydrogen (H2) breath test for carbohydrate malabsorption in children: evidence for a circadian pattern of breath H2 concentration. Pediatr Res. 1978; 12 816-823
24 Levitt M D, Hirsh P, Fetzer C A. et al . H2 excretion after ingestion of complex carbohydrates. Gastroenterology. 1987; 92 383-389
25 Bond J H Jr, Levitt M D, Prentiss R. Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements. J Lab Clin Med. 1975; 85 546-555
26 Strocchi A, Corazza G, Ellis C J. et al . Detection of malabsorption of low doses of carbohydrate: accuracy of various breath H2 criteria. Gastroenterology. 1993; 105 1404-1410
27 Tadesse K, Eastwood M. Breath-hydrogen test and smoking. Lancet. 1977; 2 91
28 Payne D L, Welsh J D, Claypool P L. Breath hydrogen (H2) response to carbohydrate malabsorption after exercise. J Lab Clin Med. 1983; 102 147-150
29 Meshkinpour H, Kemp C, Fairshter R. Effect of aerobic exercise on mouth-to-cecum transit time. Gastroenterology. 1989; 96 938-941
30 Thompson D G, Binfield P, De Belder A. et al . Extra intestinal influences on exhaled breath hydrogen measurements during the investigation of gastrointestinal disease. Gut. 1985; 26 1349-1352
31 Perman J A, Modler S, Olson A C. Role of pH in production of hydrogen from carbohydrates by colonic bacterial flora. Studies in vivo and in vitro. J Clin Invest. 1981; 67 643-650
32 Lembcke B. [Breath tests in intestinal diseases and functional gastrointestinal diagnosis]. Schweiz Rundsch Med Prax. 1997; 86 1060-1067
33 Bohmer C J, Tuynman H A. The effect of a lactose-restricted diet in patients with a positive lactose tolerance test, earlier diagnosed as irritable bowel syndrome: a 5-year follow-up study. Eur J Gastroenterol Hepatol. 2001; 13 941-944
34 Gremse D A, Nguyen duc G H, Sacks A I. et al . Irritable bowel syndrome and lactose maldigestion in recurrent abdominal pain in childhood. South Med J. 1999; 92 778-781
35 Newcomer A D, McGill D B, Thomas P J. et al . Prospective comparison of indirect methods for detecting lactase deficiency. N Engl J Med. 1975; 293 1232-1236
36 Rana S, Bhasin D K, Gupta D. et al . Assessment of optimal dose of lactose for lactose hydrogen breath test in Indian adults. Indian J Gastroenterol. 1995; 14 13-14
37 Vreugdenhil G, Sinaasappel M, Bouquet J. A comparative study of the mouth to caecum transit time in children and adults using a weight adapted lactulose dose. Acta Paediatr Scand. 1986; 75 483-488
38 Sciarretta G, Giacobazzi G, Verri A. et al . Hydrogen breath test quantification and clinical correlation of lactose malabsorption in adult irritable bowel syndrome and ulcerative colitis. Dig Dis Sci. 1984; 29 1098-1104
39 Peuhkuri K, Vapaatalo H, Nevala R. et al . Temperature of a test solution influences abdominal symptoms in lactose tolerance tests. Scand J Clin Lab Invest. 2000; 60 75-80
40 Casellas F, Malagelada J R. Applicability of short hydrogen breath test for screening of lactose malabsorption. Dig Dis Sci. 2003; 48 1333-1338
41 Veligati L N, Treem W R, Sullivan B. et al . Delta 10 ppm versus delta 20 ppm: a reappraisal of diagnostic criteria for breath hydrogen testing in children. Am J Gastroenterol. 1994; 89 758-761
42 Heyman M B, Lande W, Vichinsky E. et al . Elevated fasting breath hydrogen and abnormal hydrogen breath tests in children with sickle cell disease: a preliminary report. Am J Clin Nutr. 1989; 49 654-657
43 Gillon J, Tadesse K, Logan R F. et al . Breath hydrogen in pneumatosis cystoides intestinalis. Gut. 1979; 20 1008-1011
44 Bali A, Stableforth D E, Asquith P. Prolonged small-intestinal transit time in cystic fibrosis. Br Med J (Clin Res Ed). 1983; 287 1011-1013
45 Lewindon P J, Robb T A, Moore D J. et al . Bowel dysfunction in cystic fibrosis: importance of breath testing. J Paediatr Child Health. 1998; 34 79-82
46 Flatz G, Howell J N, Doench J. et al . Distribution of physiological adult lactase phenotypes, lactose absorber and malabsorber, in Germany. Hum Genet. 1982; 62 152-157
47 Sategna-Guidetti C, Cruto E, Capobianco P. Breath hydrogen excretion after lactose and whole milk ingestion. A prospective comparison in lactase deficiency. J Clin Gastroenterol. 1989; 11 287-289
48 Koop I. Dünndarmfunktionsdiagnostik. Koop I Gastroenterologie compact Thieme 2001: 358-360
49 DiPalma J A, Narvaez R M. Prediction of lactose malabsorption in referral patients. Dig Dis Sci. 1988; 33 303-307
50 Corazza G R, Sorge M, Strocchi A. et al . Methodology of the H2 breath test. II. Importance of the test duration in the diagnosis of carbohydrate malabsorption. Ital J Gastroenterol. 1990; 22 303-305
51 Rosado J L, Solomons N W. Sensitivity and specificity of the hydrogen breath-analysis test for detecting malabsorption of physiological doses of lactose. Clin Chem. 1983; 29 545-548
52 Hertzler S R, Huynh B C, Savaiano D A. How much lactose is low lactose?. J Am Diet Assoc. 1996; 96 243-246
53 Briet F, Pochart P, Marteau P. et al . Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect?. Gut. 1997; 41 632-635
54 Mustapha A, Jiang T, Savaiano D A. Improvement of lactose digestion by humans following ingestion of unfermented acidophilus milk: influence of bile sensitivity, lactose transport, and acid tolerance of Lactobacillus acidophilus. J Dairy Sci. 1997; 80 1537-1545
55 Montes R G, Bayless T M, Saavedra J M. et al . Effect of milks inoculated with Lactobacillus acidophilus or a yogurt starter culture in lactose-maldigesting children. J Dairy Sci. 1995; 78 1657-1664
56 Ledochowski M, Bair H, Fuchs D. Laktoseintoleranz. J Ernährungsmed. 2003; 5 7-14
57 Muller P, Meier C, Bohme H J. et al . Fructose breath hydrogen test is it really a harmless diagnostic procedure?. Dig Dis. 2003; 21 276-278
58 Osmanoglou E, Schmidtmann M, Kneifel J. et al . Fructose intolerance is frequent in patients with symptoms of irritable bowel syndrom (IBS). Gastroenterology. 2002; 122 A551 (Ref Type: Abstract)
59 Choi Y K, Johlin F C Jr, Summers R W. et al . Fructose intolerance: an under-recognized problem. Am J Gastroenterol. 2003; 98 1348-1353
60 Truswell A S, Seach J M, Thorburn A W. Incomplete absorption of pure fructose in healthy subjects and the facilitating effect of glucose. Am J Clin Nutr. 1988; 48 1424-1430
61 Ravich W J, Bayless T M, Thomas M. Fructose: incomplete intestinal absorption in humans. Gastroenterology. 1983; 84 26-29
62 Kneepkens C M, Vonk R J, Fernandes J. Incomplete intestinal absorption of fructose. Arch Dis Child. 1984; 59 735-738
63 Casellas F, Guarner L, Vaquero E. et al . Hydrogen breath test with glucose in exocrine pancreatic insufficiency. Pancreas JID - 8 608 542. 1998; 16 481-486
64 Yang C Y, Chang C S, Chen G H. Small-intestinal bacterial overgrowth in patients with liver cirrhosis, diagnosed with glucose H2 or CH4 breath tests. Scand J Gastroenterol. 1998; 33 867-871
65 Kaye S A, Lim S G, Taylor M. et al . Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome. Br J Rheumatol. 1995; 34 265-269
66 Funayama Y, Sasaki I, Naito H. et al . Monitoring and antibacterial treatment for postoperative bacterial overgrowth in Crohn’s disease. Dis Colon Rectum. 1999; 42 1072-1077
67 Attar A, Flourie B, Rambaud J C. et al . Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology JID - 0 374 630. 1999; 117 794-797
68 Mishkin D, Sablauskas L, Yalovsky M. et al . Fructose and sorbitol malabsorption in ambulatory patients with functional dyspepsia: comparison with lactose maldigestion/malabsorption. Dig Dis Sci. 1997; 42 2591-2598
69 Stotzer P O, Kilander A F. Comparison of the 1-gram (14)C-D-xylose breath test and the 50-gram hydrogen glucose breath test for diagnosis of small intestinal bacterial overgrowth. Digestion JID - 0 150 472. 2000; 61 165-171
70 Bond J H, Levitt M D. Use of breath hydrogen (H2) to quantitate small bowel transit time following partial gastrectomy. J Lab Clin Med. 1977; 90 30-36
71 Lembcke B, Bornholdt C, Kirchhoff S. et al . Clinical evaluation of a 25 g D-xylose hydrogen (H2) breath test. Z Gastroenterol. 1990; 28 555-560
72 Lo C W, Carter E A, Walker W A. Breath tests: principles, problems, and promise. Adv Pediatr. 1982; 29 105-127
73 Corazza G R, Menozzi M G, Strocchi A. et al . The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology. 1990; 98 302-309
74 Mac M M, Gibbons N, Mullins E. et al . Are hydrogen breath tests valid in the elderly?. Gerontology. 1996; 42 40-45
75 Bauer T M, Schwacha H, Steinbruckner B. et al . Diagnosis of small intestinal bacterial overgrowth in patients with cirrhosis of the liver: poor performance of the glucose breath hydrogen test. J Hepatol JID - 8 503 886. 2000; 33 382-386
76 Khin M U, Tin A, Ku T M. et al . In vitro hydrogen production by enteric bacteria cultured from children with small bowel bacterial overgrowth. J Pediatr Gastroenterol Nutr. 1992; 14 192-197
77 Caserta L, de Magistris L, Secondulfo M. et al . Assessment of intestinal permeability and orocecal transit time in patients with systemic sclerosis: analysis of relationships with epidemiologic and clinical parameters. Rheumatol Int. 2003; 23 226-230
78 Wilberg S, Pieramico O, Malfertheiner P. [The H2-lactulose breath test in the diagnosis of intestinal transit time]. Leber Magen Darm. 1990; 20 129-137
79 Sarno S, Erasmas L P, Haslbeck M. et al . Orocaecal transit, bacterial overgrowth and hydrogen production in diabetes mellitus. Ital J Gastroenterol. 1993; 25 490-496
80 Camboni G, Basilisco G, Bozzani A. et al . Repeatability of lactulose hydrogen breath test in subjects with normal or prolonged orocecal transit. Dig Dis Sci. 1988; 33 1525-1527
81 Korth H, Muller I, Erckenbrecht J F. et al . Breath hydrogen as a test for gastrointestinal transit. Hepatogastroenterology. 1984; 31 282-284
82 Casellas F, Malagelada J. Influence of the substrate on the reproducibility of the hydrogen breath test to measure the orocecal transit time. Digestion. 1998; 59 696-702
83 Wursch P, Koellreutter B, Schweizer T F. Hydrogen excretion after ingestion of five different sugar alcohols and lactulose. Eur J Clin Nutr. 1989; 43 819-825
84 Corazza G, Strocchi A, Sorge M. et al . Prevalence and consistency of low breath H2 excretion following lactulose ingestion. Possible implications for the clinical use of the H2 breath test. Dig Dis Sci. 1993; 38 2010-2016
85 Miller M A, Parkman H P, Urbain J L. et al . Comparison of scintigraphy and lactulose breath hydrogen test for assessment of orocecal transit: lactulose accelerates small bowel transit. Dig Dis Sci. 1997; 42 10-18
86 Sciarretta G, Furno A, Mazzoni M. et al . Lactulose hydrogen breath test in orocecal transit assessment. Critical evaluation by means of scintigraphic method. Dig Dis Sci. 1994; 39 1505-1510
87 Hirakawa M, Iida M, Kohrogi N. et al . Hydrogen breath test assessment of orocecal transit time: comparison with barium meal study. Am J Gastroenterol. 1988; 83 1361-1363
88 Jorge J M, Wexner S D, Ehrenpreis E D. The lactulose hydrogen breath test as a measure of orocaecal transit time. Eur J Surg. 1994; 160 409-416
89 Armbrecht U, Dotevall G, Stockbrugger R W. The effect of gastric secretion on orocoecal transit time measured with the hydrogen (H2) breath test. Z Gastroenterol. 1987; 25 145-150
90 Wildgrube H J, Classen M. [Hydrogen (H2) breath tests in the diagnosis of small intestine diseases]. Z Gastroenterol. 1983; 21 628-636
91 Riordan S M, McIver C J, Walker B M. et al . The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol JID - 0 421 030. 1996; 91 1795-1803
92 Rhodes J M, Middleton P, Jewell D P. The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth. Scand J Gastroenterol. 1979; 14 333-336
93 Jain N K, Rosenberg D B, Ulahannan M J. et al . Sorbitol intolerance in adults. Am J Gastroenterol. 1985; 80 678-681
94 Metz G, Jenkins D J, Peters T J. et al . Breath hydrogen as a diagnostic method for hypolactasia. Lancet. 1975; 1 1155-1157
95 Jain N K, Patel V P, Pitchumoni C S. Sorbitol intolerance in adults. Prevalence and pathogenesis on two continents. J Clin Gastroenterol. 1987; 9 317-319
96 Born P, Zech J, Stark M. et al . [Carbohydrate substitutes: comparative study of intestinal absorption of fructose, sorbitol and xylitol]. Med Klin (Munich). 1994; 89 575-578
97 Corazza G R, Strocchi A, Rossi R. et al . Sorbitol malabsorption in normal volunteers and in patients with coeliac disease. Gut. 1988; 29 44-48
98 Rumessen J J, Gudmand-Hoyer E. Functional bowel disease: malabsorption and abdominal distress after ingestion of fructose, sorbitol, and fructose-sorbitol mixtures. Gastroenterology. 1988; 95 694-700
99 King C E, Toskes P P. The use of breath tests in the study of malabsorption. Clin Gastroenterol. 1983; 12 591-610
100 Perman J A, Barr R G, Watkins J B. Sucrose malabsorption in children: noninvasive diagnosis by interval breath hydrogen determination. J Pediatr. 1978; 93 17-22
101 Casellas F, Malagelada J R. Follow-up of celiac disease with D-xylose breath test. Dig Dis Sci. 1996; 41 2106-2111
102 Casellas F, Malagelada J R. Clinical applicability of shortened D-xylose breath test for diagnosis of intestinal malabsorption. Dig Dis Sci. 1994; 39 2320-2326
103 Casellas F, Sardi J, Malagelada J R. Hydrogen breath test with D-xylose for celiac disease screening is as useful in the elderly as in other age groups. Dig Dis Sci. 2001; 46 2201-2205
104 Savarino V, Mela G S, Zentilin P. et al . Comparison of isotope ratio mass spectrometry and nondispersive isotope-selective infrared spectroscopy for 13C-urea breath test. Am J Gastroenterol. 1999; 94 1203-1208
105 Schadewaldt P, Schommartz B, Wienrich G. et al . Application of isotope-selective nondispersive infrared spectrometry (IRIS) for evaluation of [13C]octanoic acid gastric-emptying breath tests: comparison with isotope ratio-mass spectrometry (IRMS). Clin Chem. 1997; 43 518-522
106 Mion F, Ecochard R, Guitton J. et al . (13)CO(2) breath tests: comparison of isotope ratio mass spectrometry and non-dispersive infrared spectrometry results. Gastroenterol Clin Biol. 2001; 25 375-379
107 Leodolter A, von Arnim U, Gerards C. et al . Is the accuracy of isotope-selective non-dispersive infrared spectrometry (NDIRS) sufficient for determination of gastric emptying using the 13C-octanoic acid breath test (13C-OABT): Comparison with isotope-ratio mass spectrometry (IRMS). Gastroenterology. 2000; 118 A850 (Ref Type: Abstract)
108 Hartmann D, Schilling D, Riemann J F. [New nondispersive infrared spectrometry in 13C-urea breath tests]. Dtsch Med Wochenschr. 2003; 128 1645-1648
109 Isomoto H, Inoue K, Mizuta Y. et al . Validation of endoscopic 13C-urea breath test with nondispersive infrared spectrometric analysis in the management of Helicobacter pylori infection. Hepatogastroenterology. 2003; 50 422-425
110 Gisbert J P, Gomollon F, Dominguez-Munoz J E. et al . [Comparison between two 13C-urea breath tests for the diagnosis of Helicobacter pylori infection: isotope ratio mass spectrometer versus infrared spectrometer]. Gastroenterol Hepatol. 2003; 26 141-146
111 Kato S, Ozawa K, Konno M. et al . Diagnostic accuracy of the 13C-urea breath test for childhood Helicobacter pylori infection: a multicenter Japanese study. Am J Gastroenterol. 2002; 97 1668-1673
112 Adamek R J, Goetze O, Boedeker C. et al . 13C-methacetin breath test: isotope-selective nondispersive infrared spectrometry in comparison to isotope ratio mass spectrometry in volunteers and patients with liver cirrhosis. Z Gastroenterol. 1999; 37 1139-1143
113 Boedeker C, Goetze O, Pfaffenbach B. et al . 13C mixed-triglyceride breath test: isotope selective non-dispersive infrared spectrometry in comparison with isotope ratio mass spectrometry in volunteers and patients with chronic pancreatitis. Scand J Gastroenterol. 1999; 34 1153-1156
114 Barth E, Tugtekin I, Weidenbach H. et al . Determination of 13CO2/12CO2 ratio by IRMS and NDIRS. Isotopes Environ Health Stud. 1998; 34 209-213
115 Braden B, Haisch M, Duan L P. et al . Clinically feasible stable isotope technique at a reasonable price: analysis of 13CO2/12CO2-abundance in breath samples with a new isotope selective-nondispersive infrared spectrometer. Z Gastroenterol. 1994; 32 675-678
116 Keller J, Fliegner-Baia M, Layer P. Physical activity alters normal values of the „European standard” 13C-octanoic acid breath test. Gut. 2002; 51[Suppl III] A136 (Ref Type: Abstract)
117 Ghoos Y F, Maes B D, Geypens B J. et al . Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology. 1993; 104 1640-1647
118 Colaiocco F L, Papponetti M, Marcuccitti J. et al . 13C-urea breath test for helicobacter pylori infection: stability of samples over time. Scand J Gastroenterol. 1999; 34 942-943
119 Cutler A F, Havstad S, Ma C K. et al . Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology. 1995; 109 136-141
120 Zagari R M, Bazzoli F, Pozzato P. et al . Review article: non-invasive methods for the diagnosis of Helicobacter pylori infection. Ital J Gastroenterol Hepatol. 1999; 31 408-415
121 Malfertheiner P, Megraud F, O’Morain C. et al . Current concepts in the management of Helicobacter pylori infection the Maastricht 2 - 2000 Consensus Report. Aliment Pharmacol Ther. 2002; 16 167-180
122 Chan F K, Chung S C, Suen B Y. et al . Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med. 2001; 344 967-973
123 Gatta L, Vakil N, Ricci C. et al . Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection. Am J Gastroenterol. 2004; 99 823-829
124 Graham D Y, Opekun A R, Jogi M. et al . False negative urea breath tests with H2-receptor antagonists: interactions between Helicobacter pylori density and pH. Helicobacter. 2004; 9 17-27
125 Leung W K, Hung L C, Kwok C K. et al . Follow up of serial urea breath test results in patients after consumption of antibiotics for non-gastric infections. World J Gastroenterol. 2002; 8 703-706
126 Graham D Y, Klein P D, Evans D J Jr. et al . Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet. 1987; 1 1174-1177
127 Bell G D, Weil J, Harrison G. et al . 14C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach. Lancet. 1987; 1 1367-1368
128 Marshall B J, Surveyor I. Carbon-14 urea breath test for the diagnosis of Campylobacter pylori associated gastritis. J Nucl Med. 1988; 29 11-16
129 Vaira D, Vakil N. Blood, urine, stool, breath, money, and Helicobacter pylori. Gut. 2001; 48 287-289
130 Duggan A, Elliott C, Logan R. Testing for Helicobacter pylori infection: validation and diagnostic yield of a near patient test in primary care. Br Med J. 1999; 19 1236-1239
131 Wong B C, Wong W, Tang V S. et al . An evaluation of whole blood testing for Helicobacter pylori infection in the chinese population. Aliment Pharmacol Ther. 2000; 14 331-335
132 Vaira D, Malfertheiner P, Megraud F. et al . Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicenter study. Am J Gastroenterol. 2000; 95 925-929
133 Atherton J C. Non-endoscopic tests in the diagnosis of Helicobacter pylori infection. Aliment Pharmacol Ther. 1997; 11 (Suppl 1) 11-20
134 Megraud F, Burette A, Glupczynski Y. et al . Comparison of tests for assessment of Helicobacter pylori eradication: results of a multi-centre study using centralized facility testing. Eur J Gastroenterol Hepatol. 2000; 12 629-633
135 Cutler A F, Prasad V M. Long-term follow-up of Helicobacter pylori serology after successful eradication. Am J Gastroenterol. 1996; 91 85-88
136 Moayyedi P, Soo S, Deeks J. et al . Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ. 2000; 321 659-664
137 Malfertheiner P, Gerards C. Helicobacter pylori infection and gastro-oesophageal reflux disease: coincidence or association?. Baillieres Best Pract Res Clin Gastroenterol. 2000; 14 731-741
138 Blum A L, Talley N J, O’Morain C. et al . Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med. 1998; 339 1875-1881
139 Talley N J, Meineche-Schmidt V, Pare P. et al . Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther. 1998; 12 1055-1065
140 Chan F K, Sung J J, Chung S C. et al . Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet. 1997; 350 975-979
141 Hawkey C J, Tulassay Z, Szczepanski L. et al . Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention. Lancet. 1998; 352 1016-1021
142 Yeomans N D. New data on healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee. Am J Med. 1998; 104 56S-61S
143 Bianchi P G, Lazzaroni M, Manzionna G. et al . Omeprazole and sucralfate in the treatment of NSAID-induced gastric and duodenal ulcer. Aliment Pharmacol Ther. 1998; 12 355-360
144 Tefera S, Hatlebakk J G, Berstad A. The effect of Helicobacter pylori eradication on gastro-oesophageal reflux. Aliment Pharmacol Ther. 1999; 13 915-920
145 Imrie C, Rowland M, Bourke B. et al . Limitations to carbon 13-labeled urea breath testing for Helicobacter pylori in infants. J Pediatr. 2001; 139 734-737
146 Kindermann A, Demmelmair H, Koletzko B. et al . Influence of age on 13C-urea breath test results in children. J Pediatr Gastroenterol Nutr. 2000; 30 85-91
147 Drumm B, Koletzko S, Oberda G. Helicobacter pylori infection in children: a consensus statement. J Pediatr Gastroenterol Nutr. 2000; 30 207-213
148 Sherman P, Hassall E, Hunt R H. et al . Canadian Helicobacter Study Group Consensus Conference on the Approach to Helicobacter pylori Infection in Children and Adolescents. Can J Gastroenterol. 1999; 13 553-559
149 Chey W D, Woods M, Scheiman J M. et al . Lansoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependent mechanism. Am J Gastroenterol. 1997; 92 446-450
150 Chey W D, Spybrook M, Carpenter S. et al . Prolonged effect of omeprazole on the 14C-urea breath test. Am J Gastroenterol. 1996; 91 89-92
151 Laine L, Estrada R, Trujillo M. et al . Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori. Ann Intern Med. 1998; 129 547-550
152 Braden B, Duan L P, Caspary W F. et al . More convenient 13C-urea breath test modifications still meet the criteria for valid diagnosis of Helicobacter pylori infection. Z Gastroenterol. 1994; 32 198-202
153 Eggers R, Kulp A, Tegeler R. A methodological analysis of the 13C-urea breath test for detection of helicobacter pylori infections: high sensitivity and specificity within 30 min using 75 mg of 13C-urea. Eur J Gastroenterol Hepatol. 2003; 2 437-444
154 Klein P D, Graham D Y. Minimum analysis requirements for the detection of Helicobacter pylori infection by the 13C-urea breath test. Am J Gastroenterol. 1993; 88 1865-1869
155 Leodolter A, Wolle K, Malfertheiner P. Current standards in the diagnosis of Helicobacter pylori infection. Dig Dis. 2001; 19 116-122
156 Kuipers E J, Appelmelk B J. Helicobacter pylori and atrophic gastritis. Biomed Pharmacother. 1997; 51 150-155
157 Rektorschek M, Weeks D, Sachs G. et al . Influence of pH on metabolism and urease activity of Helicobacter pylori. Gastroenterology. 1998; 115 628-641
158 Kuipers E J, Uyterlinde A M, Pena A S. et al . Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety [see comments]. Am J Gastroenterol. 1995; 90 1401-1406
159 Rowland M, Lambert I, Gormally S. et al . Carbon 13-labeled urea breath test for the diagnosis of Helicobacter pylori infection in children. J Pediatr. 1997; 131 815-820
160 Dominguez-Munoz J E, Leodolter A, Sauerbruch T. et al . A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Gut. 1997; 40 459-462
161 Graham D Y, Runke D, Anderson S Y. et al . Citric acid as the test meal for the 13C-urea breath test. Am J Gastroenterol. 1999; 94 1214-1217
162 Ellenrieder V, Glasbrenner B, Stoffels C. et al . Qualitative and semi-quantitative value of a modified 13C-urea breath test for identification of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 1997; 9 1085-1089
163 Gatta L, Vakil N, Ricci C. et al . A rapid, low-dose, 13C-urea tablet for the detection of Helicobacter pylori infection before and after treatment. Aliment Pharmacol Ther. 2003; 17 793-798
164 Hine M K, O’Donnell J F. Incidence of urease producing bacteria in saliva. J Dent Res. 1943;
165 Richter H M. Stomach and duodenum. Kumar D. and Gustavsson S An illustrated guide to gastrointestinal motility Frome and London; John Wiley and sons ltd 1988: 163-174
166 Heading R C. Role and integration of mechanisms controlling gastric emptying. Dig Dis Sci. 1994; 39 (Suppl) 32S-34S
167 Schirra J, Katschinski M, Weidmann C. et al . Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest. 1996; 97 92-103
168 Meyer J H, Ohashi H, Jehn D. et al . Size of liver particles emptied from the human stomach. Gastroenterology. 1981; 80 1489-1496
169 Werth B, Meyer-Wyss B, Spinas G A. et al . Non-invasive assessment of gastrointestinal motility disorders in diabetic patients with and without cardiovascular signs of autonomic neuropathy. Gut. 1992; 33 1199-1203
170 Elashoff J D, Reedy T J, Meyer J H. Analysis of gastric emptying data. Gastroenterology. 1982; 83 1306-1312
171 Siegel J A, Urbain J L, Adler L P. et al . Biphasic nature of gastric emptying. Gut. 1988; 29 85-89
172 Braden B, Adams S, Duan L P. et al . The [13C]acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals. Gastroenterology. 1995; 108 1048-1055
173 Delbende B, Perri F, Couturier O. et al . 13C-octanoic acid breath test for gastric emptying measurement. Eur J Gastroenterol Hepatol. 2000; 12 85-91
174 Lee J S, Camilleri M, Zinsmeister A R. et al . A valid, accurate, office based non-radioactive test for gastric emptying of solids. Gut. 2000; 46 768-773
175 Perri F, Clemente R, Festa V. et al . 13C-Octanoic acid breath test: valueless test for gastric emptying?. Gastroenterology. 1998; 114 857-859
176 Pfaffenbach B, Wegener M, Adamek R J. et al . [Non-invasive 13C octanoic acid breath test for measuring stomach emptying of a solid test meal correlation with scintigraphy in diabetic patients and reproducibility in healthy probands]. Z Gastroenterol. 1995; 33 141-145
177 Viramontes B E, Kim D Y, Camilleri M. et al . Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying. Neurogastroenterol Motil. 2001; 13 567-574
178 Drewe J, Hildebrand D, Descloux L. et al . Further validation of the 13C-octanoic acid breath test for gastric emptying of solids. Gastroenterology. 1998; 114 A745 (Ref Type: Abstract)
179 Bromer M Q, Kantor S B, Wagner D A. et al . Simultaneous measurement of gastric emptying with a simple muffin meal using [13C]octanoate breath test and scintigraphy in normal subjects and patients with dyspeptic symptoms. Dig Dis Sci. 2002; 47 1657-1663
180 Choi M G, Camilleri M, Burton D D. et al . [13C]octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology. 1997; 112 1155-1162
181 Zahn A, Langhans C D, Hoffner S. et al . Measurement of gastric emptying by 13C-octanoic acid breath test versus scintigraphy in diabetics. Z Gastroenterol. 2003; 41 383-390
182 Maes B D, Mys G, Geypens B J. et al . Gastric emptying flow curves separated from carbon-labeled octanoic acid breath test results. Am J Physiol. 1998; 275 G169-G175
183 Choi M G, Camilleri M, Burton D D. et al . Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol. 1998; 93 92-98
184 Hildebrand D, Drewe J, Degen L. et al . 13C-octanoic acid breath test for gastric emptying of solids: meal-to-meal variability. Gastroenterology. 1998; 114 A765 (Ref Type: Abstract)
185 Lee J S, Camilleri M, Zinsmeister A R. et al . Toward office-based measurement of gastric emptying in symptomatic diabetics using [13C]octanoic acid breath test. Am J Gastroenterol. 2000; 95 2751-2761
186 Duan L P, Braden B, Caspary W F. et al . Influence of cisapride on gastric emptying of solids and liquids monitored by 13C breath tests. Dig Dis Sci. 1995; 40 2200-2206
187 Maes B D, Hiele M I, Geypens B J. et al . Pharmacological modulation of gastric emptying rate of solids as measured by the carbon labelled octanoic acid breath test: influence of erythromycin and propantheline. Gut. 1994; 35 333-337
188 Schirra J, Leicht P, Hildebrand P. et al . Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7 - 36)amide in non-insulin dependent diabetes mellitus. J Endocrinol. 1998; 156 177-186
189 Maes B D, Ghoos Y F, Geypens B J. et al . Relation between gastric emptying rate and energy intake in children compared with adults. Gut. 1995; 36 183-188
190 Maes B D, Hiele M I, Geypens B J. et al . Gastric emptying of the liquid, solid and oil phase of a meal in normal volunteers and patients with Billroth II gastrojejunostomy. Eur J Clin Invest. 1998; 28 197-204
191 Maes B D, Spitz B, Ghoos Y F. et al . Gastric emptying in hyperemesis gravidarum and non-dyspeptic pregnancy. Aliment Pharmacol Ther. 1999; 13 237-243
192 Maes B D, Ghoos Y F, Hiele M I. et al . Gastric emptying rate of solids in patients with nonulcer dyspepsia. Dig Dis Sci. 1997; 42 1158-1162
193 Perri F, Pastore M, Zicolella A. et al . Gastric emptying of solids is delayed in celiac disease and normalizes after gluten withdrawal. Acta Paediatr. 2000; 89 921-925
194 Loser C, Mollgaard A, Aygen S. et al . 13C-starch breath test comparative clinical evaluation of an indirect pancreatic function test. Z Gastroenterol. 1997; 35 187-194
195 Vantrappen G R, Rutgeerts P J, Ghoos Y F. et al . Mixed triglyceride breath test: a noninvasive test of pancreatic lipase activity in the duodenum. Gastroenterology. 1989; 96 1126-1134
196 Wutzke K D, Radke M, Breuel K. et al . Triglyceride oxidation in cystic fibrosis: a comparison between different 13C-labeled tracer substances. J Pediatr Gastroenterol Nutr. 1999; 29 148-154
197 Swart G R, Baartman E A, Wattimena J L. et al . Evaluation studies of the 13C-mixed triglyceride breath test in healthy controls and adult cystic fibrosis patients with exocrine pancreatic insufficiency. Digestion. 1997; 58 415-420
198 Perri F, Andriulli A. „Mixed” triglyceride breath test: methodological problems and clinical applications. Rev Med Univ Navarra. 1998; 42 99-103
199 Kalivianakis M, Verkade H J, Stellaard F. et al . The 13C-mixed triglyceride breath test in healthy adults: determinants of the 13CO2 response. Eur J Clin Invest. 1997; 27 434-442
200 Loser C, Brauer C, Aygen S. et al . Comparative clinical evaluation of the 13C-mixed triglyceride breath test as an indirect pancreatic function test. Scand J Gastroenterol. 1998; 33 327-334
201 van Dijk-Aalst K, Van Den D M, van Der S S. et al . 13C mixed triglyceride breath test: a noninvasive method to assess lipase activity in children. J Pediatr Gastroenterol Nutr. 2001; 32 579-585
202 Layer P, Keller J. How to make use of pancreatic function tests. Buechler MW et al Chronic Pancreatitis: Novel concepts in biology and therapy Oxford; Blackwell Science 2002: 233-242
203 Lembcke B, Braden B, Caspary W F. Exocrine pancreatic insufficiency: accuracy and clinical value of the uniformly labelled 13C-Hiolein breath test. Gut. 1996; 39 668-674
204 Braden B, Picard H, Caspary W F. et al . Monitoring pancreatin supplementation in cystic fibrosis patients with the 13C-Hiolein breath test: evidence for normalized fat assimilation with high dose pancreatin therapy. Z Gastroenterol. 1997; 35 123-129
205 De Boeck K, Delbeke I, Eggermont E. et al . Lipid digestion in cystic fibrosis: comparison of conventional and high-lipase enzyme therapy using the mixed-triglyceride breath test. J Pediatr Gastroenterol Nutr. 1998; 26 408-411
206 Fried M, Abramson S, Meyer J H. Passage of salivary amylase through the stomach in humans. Dig Dis Sci. 1987; 32 1097-1103
207 Layer P, Zinsmeister A R, DiMagno E P. Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans. Gastroenterology. 1986; 91 41-48
208 Nordgaard I, Mortensen P B. Digestive processes in the human colon. Nutrition. 1995; 11 37-45
209 Macfarlane G T, Macfarlane S. Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand J Gastroenterol Suppl. 1997; 222 3-9
210 Evenepoel P, Claus D, Geypens B. et al . Evidence for impaired assimilation and increased colonic fermentation of protein, related to gastric acid suppression therapy. Aliment Pharmacol Ther. 1998; 12 1011-1019
211 Evenepoel P, Hiele M, Geypens B. et al . 13C-egg white breath test: a non-invasive test of pancreatic trypsin activity in the small intestine. Gut. 2000; 46 52-57
212 Carriere F, Barrowman J A, Verger R. et al . Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans. Gastroenterology. 1993; 105 876-888
213 Thompson L, Spiller R C. Impact of polyunsaturated fatty acids on human colonic bacterial metabolism: an in vitro and in vivo study. Br J Nutr. 1995; 74 733-741
214 Keller J, Layer P. Pancreatic Enzyme Supplementation Therapy. Curr Treat Options Gastroenterol. 2003; 6 369-374
215 Murphy J L, Laiho K M, Jones A E. et al . Metabolic handling of 13C labelled tripalmitin in healthy controls and patients with cystic fibrosis. Arch Dis Child. 1998; 79 44-47
216 Watkins J B, Klein P D, Schoeller D A. et al . Diagnosis and differentiation of fat malabsorption in children using 13C-labeled lipids: trioctanoin, triolein, and palmitic acid breath tests. Gastroenterology. 1982; 82 911-917
217 Sun D Y, Jiang Y B, Rong L. et al . Clinical application of 13C-Hiolein breath test in assessing pancreatic exocrine insufficiency. Hepatobiliary Pancreat Dis Int. 2003; 2 449-452
218 Miyakawa S, Hayakawa M, Horiguchi A. et al . Estimation of fat absorption with the 13C-trioctanoin breath test after pancreatoduodenectomy or pancreatic head resection. World J Surg. 1996; 20 1024-1028
219 Ritz M A, Fraser R J, Di Matteo A C. et al . Evaluation of the 13C-triolein breath test for fat malabsorption in adult patients with cystic fibrosis. J Gastroenterol Hepatol. 2004; 19 448-453
220 Matsumoto K, Suehiro M, Iio M. et al . [13C]methacetin breath test for evaluation of liver damage. Dig Dis Sci. 1987; 32 344-348
221 Klatt S, Taut C, Mayer D. et al . Evaluation of the 13C-methacetin breath test for quantitative liver function testing. Z Gastroenterol. 1997; 35 609-614
222 Lara B S, Razquin M, Jimenez I. et al . 13C-phenylalanine and 13C-methacetin breath test to evaluate functional capacity of hepatocyte in chronic liver disease. Dig Liver Dis. 2000; 32 226-232
223 Mana F, Georges B, Reynaert H. et al . Evaluation of the 13C-aminopyrine breath test using nondispersive infrared spectrometry. Acta Gastroenterol Belg. 2000; 63 328-330
224 Zipprich A, Meiss F, Steudel N. et al . 13C-Methacetin metabolism in patients with cirrhosis: relation to disease severity, haemoglobin content and oxygen supply. Aliment Pharmacol Ther. 2003; 17 1559-1562
225 Opekun A R Jr, Klein P D, Graham D Y. [13C]Aminopyrine breath test detects altered liver metabolism caused by low-dose oral contraceptives. Dig Dis Sci. 1995; 40 2417-2422
226 Mion F, Queneau P E, Rousseau M. et al . Aminopyrine breath test: development of a 13C-breath test for quantitative assessment of liver function in humans. Hepatogastroenterology. 1995; 42 931-938
227 Irving C S, Schoeller D A, Nakamura K I. et al . The aminopyrine breath test as a measure of liver function. A quantitative description of its metabolic basis in normal subjects. J Lab Clin Med. 1982; 100 356-373
228 Fasoli A, Giannini E, Botta F. et al . 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis. Hepatogastroenterology. 2000; 47 234-238
229 Herold C, Regn S, Ganslmayer M. et al . Can quantitative tests of liver function discriminate between different etiologies of liver cirrhosis?. Dig Dis Sci. 2002; 47 2669-2673
230 Herold C, Ganslmayer M, Deynet C. et al . Quantitative testing of liver function compared to prognostic scores in patients with primary biliary cirrhosis. Liver. 2002; 22 159-165
231 Schneider J F, Schoeller D A, Nemchausky B. et al . Validation of 13CO2 breath analysis as a measurement of demethylation of stable isotope labeled aminopyrine in man. Clin Chim Acta. 1978; 84 153-162
232 Wensing G, Lotterer E, Ahlsdorf H. et al . Relationship of the aminopyrine breath test and the Child-Pugh score to urinary sodium retention in patients with liver cirrhosis. Z Gastroenterol. 1995; 33 150-154
233 Di Campli C, Angelini G, Armuzzi A. et al . Quantitative evaluation of liver function by the methionine and aminopyrine breath tests in the early stages of liver transplantation. Eur J Gastroenterol Hepatol. 2003; 15 727-732
234 Giannini E, Fasoli A, Chiarbonello B. et al . 13C-aminopyrine breath test to evaluate severity of disease in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther. 2002; 16 717-725
235 Pfaffenbach B, Gotze O, Szymanski C. et al . [The 13C-methacetin breath test for quantitative noninvasive liver function analysis with an isotope-specific nondispersive infrared spectrometer in liver cirrhosis]. Dtsch Med Wochenschr. 1998; 123 1467-1471
236 Tugtekin I, Wachter U, Barth E. et al . Phenylalanine kinetics in healthy volunteers and liver cirrhotics: implications for the phenylalanine breath test. Am J Physiol Endocrinol Metab. 2002; 283 E1223-E1231
237 Kobayashi T, Kubota K, Imamura H. et al . Hepatic phenylalanine metabolism measured by the [13C]phenylalanine breath test. Eur J Clin Invest. 2001; 31 356-361
238 Ishii Y, Suzuki S, Kohno T. et al . L-[1 - 13C] phenylalanine breath test reflects histological changes in the liver. J Surg Res. 2003; 114 120-125
239 Ishii Y, Suzuki S, Kohno T. et al . L-[1 - 13C] phenylalanine breath test reflects phenylalanine hydroxylase activity of the whole liver. J Surg Res. 2003; 112 38-42
240 Spahr L, Negro F, Leandro G. et al . Impaired hepatic mitochondrial oxidation using the 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis. Med Sci Monit. 2003; 9 CR6-11
241 Armuzzi A, Marcoccia S, Zocco M A. et al . Non-Invasive assessment of human hepatic mitochondrial function through the 13C-methionine breath test. Scand J Gastroenterol. 2000; 35 650-653
242 Caubet M S, Laplante A, Caille J. et al . [13C]aminopyrine and [13C]caffeine breath test: influence of gender, cigarette smoking and oral contraceptives intake. Isotopes Environ Health Stud. 2002; 38 71-77
243 Saadeh S, Behrens P W, Parsi M A. et al . The utility of the 13C-galactose breath test as a measure of liver function. Aliment Pharmacol Ther. 2003; 18 995-1002
244 Miele L, Grieco A, Armuzzi A. et al . Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. Am J Gastroenterol. 2003; 98 2335-2336
245 Petrolati A, Festi D, De Berardinis G. et al . 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther. 2003; 18 785-790

Jutta Keller

Israelitisches Krankenhaus, Medizinische Klinik

Orchideenstieg 14

22297 Hamburg

Phone: 0 40/5 11 25-50 41

Fax: 0 40/5 11 25-50 45

Email: keller@ik-h.de